chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The night of I had a fever but it wasn't over 101. Then I had aches and pains; very uncomfortable the first night. The second night I took Tylenol before I went to bed and it dropped my fever. So I was down a total of 30 hours. The other thing I noticed the morning after my coffee tasted strange. I made my husband make me another cup, but it was still strange tasting. After trying a home remedy things tasted normal again. I did not seek any medical attention.
Patient received a duplicate Fluad vaccine. She received a dose on 10/12/21 and then this dose was administered 10/26/21 as patient did not remember already receiving on 10/12/21
C/o numbness next to right eye & nausea. 1350 BP 146/80, P 80, T 97.8, R 18. 1410 BP 108/60 c/o headache & nausea. 1520 back to classroom feeling better.
Pt was given second dose in supine position due to reaction for first dose.  Pt c/o nausea, dizziness, rapid heart rate, and chest tightness @9:24 ~5mins after vaccination.  @9:24 BP 128/65, HR 80, RR 20 -- > @9:33 121/52, 79, 20.  Pt symptoms improved. Pt stable and released from the vaccination site w/ husband.  Recommended that the pt f/u with their healthcare provider.  Instructions provided.
the noc of the day he received shots he fussed like he was hungry and mom went to feed him. He ate part of bottle feeding, and seemed tired; limps somewhat "Lethargic", eyes rolled back a little and he felt cold and clammy. Temp was 97.0 wo color changes. Mom held him awhile and put him back to bed and did fine.
Day after injection started itching all over. Started BENADRYL. Itching persisted and sought medical attention on 10/24/17. Started MEDROL DOSEPAK. Itching continues but decreased at this time.
Information has been received from a 38 year old female consumer with an allergy to sulfa who was vaccinated with "three doses one month apart" of hepatitis B virus vaccine rHBsAg (yeast). She did not experience andy side effects other than a sore arm. Medical attention was sought. No laboratory diagnostic tests were performed. There was no product quality complaint involved.
they have administered expired ACTHIB to a patient, with no reported AE; Initial information received on 28-Sep-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 3 years old male patient to whom they have administered expired HIB (PRP/T) vaccine [ACT-HIB], with no reported ae (adverse event).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis A vaccine and pneumonia vaccine  for Immunisation.  On an unknown date, the patient received suspect HIB (PRP/T) Vaccine, Powder and solvent for solution for injection via unknown route in unknown administration site for immunization, expiry date: 11-SEP-2023 (strength, dose, batch: unknown) administered expired acthib to a patient, with no reported ae (expired product administered) (latency same day). Information on the batch number was requested  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event expired product administered.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
9NOV96 arm red, hard knot (size of fist);10NOV96 redness extended down arm & up shoulder;11NOV96 redness in 2" line extended further down arm;seen @ urgent care tx w/Keflex;
diagnosed with Mono today; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 18-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on an unspecified date (at the age of 18-year-old), as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had first dose and due for the second dose next Wednesday. On unspecified date patient was diagnosed with Mono (today). The Urgent Care doctor said it would be fine to go get it. Her Primary said to wait a couple of weeks. Reporter asking can she got the second dose of vaccine and would the second dose be less effective if patient waited for second dose. The clinical outcome of the events was unknown.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
After receiving the first dose  patient started to feel itchiness.  0.5ml of Benadryl given to the patient RD Vitals were stable and symptoms resolved before she left the office.
1 week after shot I ,got " arm" that lasted 4 days along with chills and  very sore/ achy legs making it hurt to walk. I still have leg achyness and dizziness that prompted me to call my doctor to note it in my chart. on March 1, 2021. I soaked my legs in an upsom salt bath for comfort.   I now have light bruises on my legs and some feet and left hand tingling/numbnes.  My heart rate is elevated at different times of the day with simple movement; walking to kitchen or bathroom. Some dizziness/brain fog at given moments throughout the day.
my son got the 1st & 2nd doses of the Moderna Covid-19 vaccine. He's only 17 years old.; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my son got the 1st & 2nd doses of the Moderna Covid-19 vaccine. He's only 17 years old.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058A21A and 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my son got the 1st & 2nd doses of the Moderna Covid-19 vaccine. He's only 17 years old.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 12-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my son got the 1st & 2nd doses of the Moderna Covid-19 vaccine. He's only 17 years old.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.            No concomitant medications are provided. No treatment medications are provided.   This case was linked to MOD-2021-390055 (Patient Link).
Information has been received from a nurse practitioner concerning a patient who on 09-JUL-2008 was vaccinated with the third dose of ROTATEQ 2ml orally. The patient vomited while receiving the third dose of ROTATEQ. The patient did not experience any known symptoms. Additional information has been requested.
Patient reported hot, red rash at injection site. She f/u w/ provider and was prescribed 10 days of antibiotics (KEFLEX).
8 patients got expired vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported. Reporter stated patient has not reported any adverse reactions to the dose so far.
FEVER, ACHY, BAD HEADACHE, DIARRHA, STOMACH CRAMPS
Pain at injection site, fatigue, headache, myalgia, very cold, nausea and vomiting, fever, had insomnia, took Tylenol
Patient given Covid vaccine at 0906, patient remained at clinic post injection to observe for signs of allergic reaction. At 0920, patient c/o lip tingling & itching to chest & hands. Provider assessed patient and Benadryl 50 mg IM given at 0925. VS obtained temp 98.9, HR 73, RR 20, BP 154/106, O2 sat 99% RA. patient reports she has not taken her BP meds yet this morning. Patient took BP meds at 0950 in presence of provider. Patient speaking in clear, complete sentences without respiratory distress. Airway patient, skin is warm & dry, mild erythema to upper chest noted where patient was scratching/no rash present. VS rechecked at 1020 temp 97.6, HR 65, RR 20, BP 140/97, O2 sat 98% RA. Patient reports she is feeling better & does not feel bad or itch as intensely as she did initially. 1025 Patient discharged home with instructions to notify PCP if symptoms worsen or go to nearest ER. Patient verbalized understanding.
Chronic itch and spontaneous hives. I had ?COVID arm? after my first dose.  It resolved in a week. Six days after my 2nd dose I developed a red splotchy rash on my upper left thigh. No itching. It resolved in a few weeks. About a month after I began to have random itching on my palms, stomach, back, neck, and chest. This last until July when I had a full allergy attack. I had hives covering my arms. I received a steroid shot and it resolved. Random itching continued but nothing worth noting. Early August I then developed a very itchy and red rash on my face, neck, and chest. Another steroid shot but this ain?t resolve much of anything. I began having flashing episodes due to the steroid shot. After that subsided my itching was still mild. I now take Zyrtec sailing. If I continue, no issues. But if I go longer than 24 hours my chest/neck gets red, hot, and itchy. I then will develop sporadic hives on my stomach.  The resolve in 15-30 minutes but the itching remains. My skin welps and reddens when touched by random things.
Dose 2 of the vaccine was administered before 4-day grace period. Per CDC website, if second dose of vaccine is given fewer than 24 days after first dose for Moderna (earlier than 4 day grace period), do NOT repeat dose. Per at Moderna, she confirmed this info. Info was relayed to patient that another dose is not needed per CDC and Moderna.
woke w/muscle, body, h/a;arm hurts @ site;devel chest;cold overnoc;dizzy, coughing phlegm;dx virus bronchitis;
Intussusception => vomiting 8 days after vaccines; air contrast barium enema diagnosed and reduced intussusception.
Back pain; Tested positive of COVID-19; Fatigue; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014CZIA) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included ENALAPRIL, LINAGLIPTIN (TRADJENTA), LEVOTHYROXINE and TAMSULOSIN for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced BACK PAIN (Back pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills). On 03-May-2021, BACK PAIN (Back pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Apr-2021, SARS-CoV-2 test: positive (Positive) tested positive of covid19 (twice). On 15-May-2021, SARS-CoV-2 test: positive (Positive) tested positive again on the  15MAy2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Information has been received from a licensed visiting nurse concerning a 5 year old Caucasian male with no significant past medical history and NKDA who on 02/20/97 was vaccinated with the first dose of varicella virus vaccine live, left thigh SC. The pt also received the first of tuberculin purified protein derivative (Tubersol) IM in the left forearm. There was no other concomitant medication. On 10/31/01, the pt was presented in the office with an active case of chicken pox, confirmed "breakthrough varicella" following exposure at school. The pt had 10 pox scattered across the face, neck, and chest. There were no pox on arms or legs. The patient was not febrile. It was noted that the pt had no coexisting conditions at the time of the vaccinations or at the time of exposure at school. The pt sought unspecified medical attention. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of chills in a 62-year-old female patient who received SHINGRIX for prophylaxis. On 19th August 2018, the patient received SHINGRIX. On 19th August 2018, less than a day after receiving SHINGRIX, the patient experienced chills, pain, nausea, fatigue, fever and headache. On 20th August 2018, the patient experienced feeling bad. On an unknown date, the outcome of the chills, nausea, fever and headache were recovered/resolved and the outcome of the pain and fatigue were not recovered/not resolved and the outcome of the feeling bad was unknown. It was unknown if the reporter considered the chills, pain, nausea, fatigue, fever, headache and feeling bad to be related to SHINGRIX. Additional details reported as follows: The age at vaccination was not reported. The evening of vaccination she had severe headache. She had a little bit of nausea and had been feeling fatigued and achy. On 20th August 2018, 1 day after vaccination the patient felt bad, but felt a little better Tuesday morning. By 6 PM Tuesday, 21st August 2018, she had to take Tylenol again because the headache and fever had come back. On 22nd August 2018, this morning, she was feeling better except that she still feels tired and achy. This experience had felt like the worst case of flu that she has had.
Red rash around the injection site. Called doctor and he told me it was "Covid Arm" he told me to take Tylenol for pain our discomfort but said that it should go away by itself.
mom called & stated that pt began breaking out in hives approx 1- 1 1/2 hrs p/vax stated the hives 1st appeared on chest & then spread to back & legs; gave DPH; 2 1/2 hrs p/hives appeared stopped the progression;
Diagnosed with type 1 diabetes in July 2021 after months of weight loss, and excessive thirst which began after receiving the first vaccine in April 2021.
A) One of the vaccines given was expired at the time of administration. It was lot number 1001460 of DTaP. It expired Jun 11 2000. We just recently learned of this problem. B) The parents reported on Aug 26 2000 that their child had developed recurrent vomiting. Initially they felt it began one week after the injections. On Sep 8 2000 they reported the first episode occured 4 days after the injection. On Sep 28 2000, they reported it began on Jul 29 2000. Now they report within a day of the vaccine the child appeared ill. The recurrent vomiting was initially diagnosed as cyclic vomiting although he had an abnormal EEG. He had no response to Verapamil and then developed a grand mal seizure and was diagnosed with partial complex seizures. He developed difficulties in school and was then diagnosed as having oculomotor apraxia and a learning disorder as well. Of course, when the parents were informed of the expiration-problem, they were concerned that this may have been the cause of his neurologic concerns. - 2/1/06 Review of medical records essentially confirms the cyclic vomiting and abnormal EEG (9/2000 notes and test results), and subsequent development of seizures (2003 MRI listed reason for test as 'seizure'). Additional symptoms noted at time of AE onset, but not on VAERS report, include pale, clammy, headache, and fuzzy vision. Information received from 60 day follow up states patient has persistent epileptic activity. Patient remains on anticonvulsant therapy & had a seizure unprovoked 6 weeks ago.  Has continued learning disorder that eresged with seizure disorder August 2000.
Pericarditis 3 days after 1st dose of Pfizer COVID-19 vaccine.
This spontaneous report as received from a pharmacist via field employee refers to a female patient of unknown age. In March 2014 the patient was vaccinated with a dose of ZOSTAVAX (lot#, strength, dosage, route and unknown). On unspecified date, in 2014, the patient developed unspecified symptoms after receiving ZOSTAVAX. The patient was treated with VALTREX. The outcome of the event was unknown. The causality between the event and ZOSTAVAX was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The pertinent medical history and concomitant medication was not reported. On 12-JUN-2015, the patient was vaccinated with unspecified number of improperly stored doses of MMR II (lot: K004949 and Expiry: 04-APR-2016) (route unspecified). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Client received her 1st dose Covid19 Moderna vaccine (Lot# 048C21A) on 08/17/21 at 13:03.  Approximately 20 ? 25 minutes later, while driving home, the client stated her eyes and lips started itching.  She also noticed puffiness in her eyes and numbness in her lips. Client stated she did not experience swelling of the lips, tongue, or throat.  She also declined that difficulty breathing, shortness of breath, or chest pain occurred.  The client did not take anything for these symptoms or seek medical attention.  However, she did use a cold compress for the puffiness of her eyes.  Client stated the symptoms lasted 3 days and subsided on their own.  Client also stated the only other symptom she experienced after receiving her 1st dose of the COVID19 Moderna vaccine was discomfort in her arm where she received the injection.  Client has no underlying health conditions, takes no medications, and has no known allergies.  Client did state she received a Tribedoce shot, which is a Vitamin B cocktail with Diclofenac, 2 days prior to receiving her 1st Covid19 Moderna vaccine.  She had never received that type of shot before.  Before proceeding with the administration of the client?s 2nd dose of Covid19 Moderna vaccine Lead RN conducted a medical consult with a Clinical Lead.  In turn, the Clinical Lead consulted with County Doctor, who approved the administration of a 2nd dose of the Covid19 Moderna vaccine (Lot# 014F21A) with a 30-minute observation for the client.  Lead RN administered the vaccine to the client at 15:15. Lead RN also educated the client on both the potential side effects and adverse effects of the vaccine, when to seek medical attention, and ER precautions.  Lead RN escorted the client to the observation area where she was monitored by the EMT for 30 minutes.  During that period, the client reported no discomfort or symptoms.  The Lead RN observed the client leave the observation area at 16:00 walking safely with a steady gait.
Headache, Myalgia, NauseaVomiting, cold, couldn't move left arm above shoulder, tingling in left hand, left side painful  Narrative:   Other Relevant History:
20 minutes after vaccination Pt c/o burning/tingling at injection site (lt arm) that radiates across the chest to rt arm. Pt denies any DIB, chest pain, SOB, tongue or lip tingling/swelling.  Swelling and hot to the touch noted at injection site. Pt given 50mg of Benadryl IM to rt arm.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm ) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012a21a) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMINS NOS for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm ). On 27-Feb-2021, PAIN IN EXTREMITY (sore arm ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication includes blood pressure, cholesterol and antireflects. No treatment information provided. This is a spontaneous case concerning a 66-year-old, male patient with no relevant medical history, who experienced the unexpected, non serious event of pain in extremity. The event pain in extremity occurred the same day with the first dose of mRNA-1273 vaccine administration. The rechallenge was positive. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-392066, MOD-2021-392099 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 66-year-old, male patient with no relevant medical history, who experienced the unexpected, non serious event of pain in extremity. The event pain in extremity occurred the same day with the first dose of mRNA-1273 vaccine administration. The rechallenge was positive. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
ITP noted appx 4 wks after 1st dose with heavy vaginal bleeding responsive to IVIG and steroids.
Pt recv vax on 11/10/98; on 11/11/98 pt exp fever (102.2)
DTaP injection on left deltoid given Tuesday 9/28/04. On 9/30/04, developed swollen, itchy, hot to touch area at site of DTaP. Seen by doctor at office. Rx given. Follow up report received 02/22/2005: vaccine lot numbers updated.
Itching about 20 minutes after followed by  rosy cheeks and blood shot eyes about 1 hour after injection  Took 2 Benadryl
Redness, pain and swelling developed on 1/25/2018 she came to urgent care for evaluation on 1/26 Dx cellulitis. 3X3 red, swollen and painful area noted. Treated with KEFLEX 500mg 3times daily for 7 days.
My signs and symptoms begin the next morning I had a rash on my chest neck and face and my throat was a little swollen